We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
-14.6%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$68.5B
AUM Growth
-$9.16B
Cap. Flow
+$4.06B
Cap. Flow %
5.93%
Top 10 Hldgs %
21.45%
Holding
3,375
New
359
Increased
2,433
Reduced
285
Closed
282

Top Buys

Rank Stock Value
1
LIN icon
Linde
LIN
+$124M
2
AAPL icon
Apple
AAPL
+$110M
3
MSFT icon
Microsoft
MSFT
+$104M
4
AMZN icon
Amazon
AMZN
+$71.3M
5
WBD icon
Warner Bros
WBD
+$69.6M

Top Sells

Rank Stock Value
1
T icon
AT&T
T
+$61.6M
2
CERN
Cerner Corp
CERN
+$50.9M
3
NXPI icon
NXP Semiconductors
NXPI
+$31.4M
4
AZPN
ASPEN TECHNOLOGY INC
AZPN
+$30.4M
5
YUMC icon
Yum China
YUMC
+$16.3M

Sector Composition

Rank Sector Weight
1 Technology 23.13%
2 Healthcare 14.42%
3 Financials 13.45%
4 Consumer Discretionary 10.49%
5 Industrials 9.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CVLG icon
2601
Covenant Logistics
CVLG
$872M
$408K ﹤0.01%
32,552
-968
-3% -$10.4K
BW icon
2602
Babcock & Wilcox
BW
$1.39B
$407K ﹤0.01%
67,578
+1,882
+3% +$13.2K
SEI
2603
Solaris Energy Infrastructure
SEI
$3.55B
$407K ﹤0.01%
37,430
-1,837
-5% -$22.1K
ICPT
2604
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$406K ﹤0.01%
29,409
+1,210
+4% +$19.4K
XXII
2605
22nd Century Group
XXII
$1.48M
0
FMTX
2606
DELISTED
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
$405K ﹤0.01%
58,732
+15,182
+35% +$107K
ARCT icon
2607
Arcturus Therapeutics
ARCT
$211M
$404K ﹤0.01%
25,698
-1,229
-5% -$24.1K
CTLP
2608
DELISTED
Cantaloupe
CTLP
$404K ﹤0.01%
72,103
+14,495
+25% +$77K
KBAL
2609
DELISTED
Kimball International
KBAL
$402K ﹤0.01%
52,437
+2,844
+6% +$23.3K
ROVR
2610
DELISTED
Rover Group, Inc. Class A Common Stock
ROVR
$401K ﹤0.01%
+106,715
New +$550K
RILYK
2611
DELISTED
BRC Group Holdings 5.50% Senior Notes Due 2026
RILYK
$400K ﹤0.01%
+16,675
New +$408K
AXGN icon
2612
Axogen
AXGN
$2.5B
$398K ﹤0.01%
48,559
+7,285
+18% +$62.3K
PRTS icon
2613
CarParts.com
PRTS
$54.7M
$398K ﹤0.01%
5,738
+777
+16% +$56.7K
ALBO
2614
DELISTED
Albireo Pharma Inc
ALBO
$395K ﹤0.01%
19,873
+1,903
+11% +$50.2K
NWPX icon
2615
NWPX Infrastructure Inc
NWPX
$1.15B
$394K ﹤0.01%
13,168
+342
+3% +$10.2K
KOD icon
2616
Kodiak Sciences
KOD
$2.84B
$393K ﹤0.01%
51,444
+15,578
+43% +$109K
TCBX icon
2617
Third Coast Bancshares
TCBX
$738M
$393K ﹤0.01%
+17,960
New +$417K
ULCC icon
2618
Frontier Group Holdings
ULCC
$1.7B
$393K ﹤0.01%
41,950
+6,339
+18% +$64.1K
AVNW icon
2619
Aviat Networks
AVNW
$273M
$392K ﹤0.01%
15,662
+1,718
+12% +$49.7K
GLUE icon
2620
Monte Rosa Therapeutics
GLUE
$1.34B
$392K ﹤0.01%
40,550
+16,358
+68% +$164K
KODK icon
2621
Kodak
KODK
$983M
$392K ﹤0.01%
84,459
+36,157
+75% +$189K
SKIL icon
2622
Skillsoft
SKIL
$81.6M
$392K ﹤0.01%
+5,566
New +$574K
KNSA icon
2623
Kiniksa Pharmaceuticals
KNSA
$5.93B
$388K ﹤0.01%
40,044
+4,650
+13% +$43.4K
JPM.PRL icon
2624
JPMorgan Chase & Co 4.625% Series LL Preferred Stock
JPM.PRL
$1.35B
$387K ﹤0.01%
+19,500
New +$392K
CENN icon
2625
Cenntro
CENN
$8.43M
$386K ﹤0.01%
+426
New +$451K

Similar funds

RhumbLine Advisers's Q2 2022 Portfolio in Review

As of Q2 2022, RhumbLine Advisers held 3,375 positions worth $68.5B, down 12% from $77.7B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

RhumbLine Advisers deployed $4.06B of net new capital in Q2 2022, opening 359 new positions and adding to 2,433 existing holdings. Its largest new stake was Aspen Technology Inc: 81,883 shares worth $15M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 25% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was AT&T, an estimated $61.6M trimmed.

  • RhumbLine Advisers's largest Q2 2022 buy was Aspen Technology Inc: 81,883 shares worth $15M.
  • RhumbLine Advisers added most to Linde in Q2 2022, an estimated $124M increase.
  • RhumbLine Advisers's biggest Q2 2022 reduction was AT&T, cutting an estimated $61.6M.
  • RhumbLine Advisers fully exited Cerner Corp in Q2 2022, selling an estimated $50.9M.
  • RhumbLine Advisers's ten largest holdings make up 21% of its $68.5B portfolio in Q2 2022.
  • RhumbLine Advisers opened 359 new positions and closed 282 in Q2 2022.
  • RhumbLine Advisers's portfolio value fell 12% quarter-over-quarter to $68.5B.

Based on RhumbLine Advisers's 13F filing for Q2 2022, filed 11 Aug 2022.